LENZ
LENZ Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.50
−0.14%Margins
Gross margin
80.2%
EBITDA margin
-1148.0%
EBIT margin
-1211.2%
Net margin
-1135.0%
FCF margin
-1033.3%
-73.1%
Return on equity
-66.9%
Return on assets
-78.0%
Return on invested capital
0.06x
Asset turnover
-$127.6M
Cash from operations
$6.28
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026